California Says 'Yes' to Stem-Cell Research
By Jonathan Knight,
Nature
| 11. 03. 2004
$3-billion initiative will fund creation of human cell lines
George W. Bush has won the presidential election. But Republicans are not the only ones celebrating the poll results: biologists who wish to pursue human embryonic stem-cell research have also had good news. All they have to do is move to California, if they aren't already there, and apply for a share of the $3 billion that voters have just approved for their field.
By 59% to 41% of votes, Californians said "yes" to Proposition 71, the California Stem Cell Research and Cures Initiative, which will raise around $300 million a year for a decade through bond sales.
The money will pay for research that has not been eligible for government money since 9 August 2001, when President George W. Bush limited federal spending on human embryonic stem-cell research to cell lines in existence as of that date. The creation of new cell lines involves the destruction of a days-old human embryo.
Most biomedical researchers believe that the number of lines available under the 2001 rule will be inadequate to realize the potential of stem-cell research, which might give insight...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...